Antithrombin III Deficiency: Clinical Trials

1 trial for Antithrombin III Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Antithrombin III Deficiency: new trials by email Literature Review of Antithrombin III Deficiency trials Research Report on Antithrombin III Deficiency

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate
Plasma-derived AT-III concentrate - Antithrombin III Deficiency
Phase 2 / Phase 3TerminatedInstituto Grifols, S.A.32008-04-152026-10-07

Narrower conditions

Hematologic Diseases (1)  ·  Hemostatic Disorders (1)

Broader conditions

Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Thrombophilia (1)  ·  Vascular Diseases (1)

Sponsors

Instituto Grifols, S.A. (1)